Font Size
A
A
A

Understanding Bladder Control Medications (cont.)

Botox Injection

Botox (onabotulinumtoxinA) injection has recently been approved by the Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) for patients who have failed to respond to standard therapy with anticholinergic medications.

Overactive bladder is a type of urinary incontinence caused by overactivity of the muscles in the bladder, causing frequent squeezing of the bladder and, thus, frequent urge to urinate. Botox can be injected into the bladder directly through a cystoscope (catheter with a camera going into the bladder via the urethra).

Common side effects of Botox injection may include incomplete emptying, urinary tract infection, and painful urination.

For More Information

Incontinence and Medical Links Library

Medically reviewed by Michael Wolff, MD; American Board of Urology

REFERENCE:

United States. Food and Drug Administration. "FDA Approves Botox to Treat Overactive Bladder." Jan. 18, 2013. <http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336101.htm>.


Medically Reviewed by a Doctor on 2/3/2015
Medical Author:

Must Read Articles Related to Understanding Bladder Control Medications

Incontinence
Incontinence Urinary incontinence is when there's an invo...learn more >>
Incontinence FAQs
Incontinence FAQs Get answers to frequently asked questions about ...learn more >>

Read What Your Physician is Reading on Medscape

Bladder Management »

In the practice of physical medicine and rehabilitation, voiding disorders are usually a result of neurologic conditions, such as spinal cord injury (SCI) or disease, cerebrovascular accident (CVA), traumatic brain injury (TBI), multiple sclerosis (MS), or dementia.

Read More on Medscape Reference »


Medical Dictionary